This study discovered 28 differential metabolites, five of which were discriminatory for LN from SLE and significantly associated with urea, creatinine, Cystatin C and C1q, not observed in healthy controls and reiterating the importance of a control group for validation. The gene discussed is CST3; the disease is lobular neoplasia.